Short answer
Inogen Inc (INGN) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $79M (up 5.6% year over year) with net income of −$5M.
Q3 2025 key financials · XBRL
- Revenue
- $79M
- +5.6% YoY · −0.1% QoQ
- Net income
- −$5M
- +11.2% YoY · −27.5% QoQ
- Operating margin
- -9.0%
- Gross margin
- 52.2%
- EPS (diluted)
- −$0.19
- +24.0% YoY · −26.7% QoQ
Source: XBRL data from the Inogen Inc (INGN) Q3 2025 10-Q on SEC EDGAR. USD.
Inogen Inc Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material risk-factor changes from the December 31, 2024 Form 10-K
- Liquidity risk: operating cash use $10.3 million versus $8.9 million provided in 2024
- Financing risk: $27.2 million common-stock issuance funded nine-month financing activities
- Legal risk: $2.4 million in legal and settlement expenses reduced operating cash flow
- Currency risk: 10% adverse exchange-rate movement could reduce revenue by $8.4 million before hedging
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.